Organigram to acquire Aurora Cannabis for about C$561M, backed by BAT private placement and ATB credit facilities
Organigram Global and Aurora Cannabis signed an arrangement agreement on November 2, 2026 (announced November 3) for Organigram to buy all Aurora shares through a court-approved plan of arrangement. Aurora holders can choose C$7.80 per share in cash, shares, or a mix, subject to proration. Funding includes a C$187.5M private placement from British American Tobacco's subsidiary and up to C$210M in ATB senior secured credit facilities. Aurora can still consider a superior proposal, which may include Curaleaf's existing hostile bid if its terms change, and both sides have termination and reverse-termination fees.
Company's press release (SEC filing): Organigram Global Inc. ↗
Brief written by VigiEye from the company's press release filed with the SEC. Claims are the company's own. AI-assisted; check the source before acting.
IndustryCompany releaseIM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M
IndustryCompany releaseHelus Pharma, formerly Cybin, reports $150.9M six-month net loss as share compensation rises
IndustryCompany releaseIM Cannabis sells German arm to CEO-controlled Slil, refocusing on Israel
IndustryCompany releaseDataMEDS AI Q3 revenue up 50% to $2.7M on GLP-1 dispensing
IndustryCompany releaseXenetic reports Q3 loss, advances all-stock Santersus deal and doses first DNase I CAR-T patient
IndustryCompany release